Significant capital continues to flow into innovative technology sectors with a $1.5 billion round for a medical device leader and a $700 million Series A for an AI startup specializing in personalized hardware capturing the spotlight.
- MiRus secures $1.5B for orthopedic implants with Boston Scientific stake
- Hark raises $700M Series A for personalized AI gadgets with top chipmakers backing
- Frontier AI labs and aerospace firms attract multi-hundred million dollar rounds
What happened
The largest funding round this week was a $1.5 billion investment in MiRus, a medical device company focused on orthopedic and spinal implant technologies. This round was led by Boston Scientific, which acquired a 34% equity stake, bringing MiRus’s total capital raised to around $1.6 billion. Their innovations address musculoskeletal disorders, signaling strong strategic interest from established healthcare investors.
In the AI sector, Hark, a one-year-old startup based in San Jose, completed an impressive $700 million Series A round. The company is developing personalized artificial intelligence devices and has garnered backing from major technology and venture firms including Nvidia, Intel Capital, AMD, Qualcomm Ventures, and Salesforce Ventures. Hark plans to introduce a product by late summer, highlighting rapid progression in consumer-facing AI hardware.
Why it matters
The substantial investment in MiRus underscores a renewed investor focus on tangible, physical technology innovations after a recent emphasis on software solutions. This large funding round suggests confidence in hardware-driven healthcare advancements capable of addressing chronic medical conditions with advanced implant systems.
Meanwhile, Hark’s significant funding and high-profile backers reflect surging interest in AI applications that deliver personalized and hardware-integrated experiences. This indicates an emerging market for AI devices beyond traditional cloud-based models, with potential impacts on consumer engagement and technology adoption across industries.
What to watch next
Following MiRus’s infusion of capital and strategic partnership with Boston Scientific, industry watchers should track their product development progress and upcoming clinical deployments. Success could spur further investment in orthopedic innovations and expand the medical device market segment.
For Hark, key developments will include the actual launch and market reception of its first AI device later this summer. Given its impressive investor roster, the startup’s trajectory will be a bellwether for personalized AI hardware trends, potentially influencing future venture funding patterns and technology ecosystems.